Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 901 AL 915

APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease

Lin AL, Parikh I, Yanckello LM, White RS, Hartz AMS, Taylor CE, McCulloch SD, Thalman SW, Xia M, McCarty K, Ubele M, Head E, Hyder F, Sanganahalli BG.

Neurobiol Dis. 2020 Jun;139:104834. doi: 10.1016/j.nbd.2020.104834. Epub 2020 Mar 12.

Blood fatty acids in Alzheimer's disease and mild cognitive impairment: A meta-analysis and systematic review

Hosseini M, Poljak A, Braidy N, Crawford J, Sachdev P.

Ageing Res Rev. 2020 Jul;60:101043. doi: 10.1016/j.arr.2020.101043. Epub 2020 Mar 16.

Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods

Habes M, Grothe MJ, Tunc B, McMillan C, Wolk DA, Davatzikos C.

Biol Psychiatry. 2020 Jul 1;88(1):70-82. doi: 10.1016/j.biopsych.2020.01.016. Epub 2020 Jan 31.

One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults

Martinez AI, Abner EL, Jicha GA, Rigsby DN, Eckmann LC, Huffmyer MJ, Moga DC.

J Manag Care Spec Pharm. 2020 Apr;26(4):520-528. doi: 10.18553/jmcp.2020.26.4.520.

Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant

Gonçalves ECD, Baldasso GM, Bicca MA, Paes RS, Capasso R, Dutra RC.

Molecules. 2020 Mar 29;25(7):1567. doi: 10.3390/molecules25071567.

Modulation of gamma oscillations as a possible therapeutic tool for neuropsychiatric diseases: A review and perspective

Strüber D, Herrmann CS.

Int J Psychophysiol. 2020 Jun;152:15-25. doi: 10.1016/j.ijpsycho.2020.03.003. Epub 2020 Mar 30.

Association between chronic kidney disease and Alzheimer's disease: an update

Zhang CY, He FF, Su H, Zhang C, Meng XF.

Metab Brain Dis. 2020 Aug;35(6):883-894. doi: 10.1007/s11011-020-00561-y. Epub 2020 Apr 3.

Initiation of symptomatic medication in Alzheimer's disease clinical trials: Hypothetical versus treatment policy approach

Donohue MC, Model F, Delmar P, Volye N, Liu-Seifert H, Rafii MS, Aisen PS; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2020 May;16(5):797-803. doi: 10.1002/alz.12058. Epub 2020 Apr 8.

Influence of the Mediterranean and Ketogenic Diets on Cognitive Status and Decline: A Narrative Review

Vinciguerra F, Graziano M, Hagnäs M, Frittitta L, Tumminia A.

Nutrients. 2020 Apr 8;12(4):1019. doi: 10.3390/nu12041019.

What works and what does not work in Alzheimer's disease? From interventions on risk factors to anti-amyloid trials

Bullain S, Doody R.

J Neurochem. 2020 Sep;155(2):120-136. doi: 10.1111/jnc.15023. Epub 2020 May 9.

A comparison of resting state EEG and structural MRI for classifying Alzheimer's disease and mild cognitive impairment

Farina FR, Emek-Savaş DD, Rueda-Delgado L, Boyle R, Kiiski H, Yener G, Whelan R.

Neuroimage. 2020 Jul 15;215:116795. doi: 10.1016/j.neuroimage.2020.116795. Epub 2020 Apr 8.

Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer's Disease: A Systematic Review

Clay F, Howett D, FitzGerald J, Fletcher P, Chan D, Price A.

J Alzheimers Dis. 2020;75(1):23-43. doi: 10.3233/JAD-191218.

Are ketogenic diets promising for Alzheimer's disease? A translational review

Lilamand M, Porte B, Cognat E, Hugon J, Mouton-Liger F, Paquet C.

Alzheimers Res Ther. 2020 Apr 14;12(1):42. doi: 10.1186/s13195-020-00615-4.

Glycogen synthase kinase-3: The missing link to aberrant circuit function in disorders of cognitive dysfunction?

Manduca JD, Thériault RK, Perreault ML.

Pharmacol Res. 2020 Jul;157:104819. doi: 10.1016/j.phrs.2020.104819. Epub 2020 Apr 17.

Nutritional Ketosis and photobiomodulation remediate mitochondria warding off Alzheimer's disease in a diabetic, ApoE4+ patient with mild cognitive impairment: A case report

Horner S, Berger L, Gibas K.

Photodiagnosis Photodyn Ther. 2020 Jun;30:101777. doi: 10.1016/j.pdpdt.2020.101777. Epub 2020 Apr 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias